| Year |
Citation |
Score |
| 2022 |
de Bartolomeis A, Barone A, Buonaguro EF, Tomasetti C, Vellucci L, Iasevoli F. The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight. Neuroscience and Biobehavioral Reviews. 136: 104596. PMID 35248676 DOI: 10.1016/j.neubiorev.2022.104596 |
0.725 |
|
| 2021 |
Barone A, Signoriello S, Latte G, Vellucci L, Giordano G, Avagliano C, Buonaguro EF, Marmo F, Tomasetti C, Iasevoli F, de Bartolomeis A. Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: translational inference from a postsynaptic density Immediate-Early Gene-based network analysis. Behavioural Brain Research. 113160. PMID 33577880 DOI: 10.1016/j.bbr.2021.113160 |
0.789 |
|
| 2020 |
De Berardis D, Fornaro M, Anastasia A, Vellante F, Olivieri L, Rapini G, Serroni N, Orsolini L, Valchera A, Carano A, Tomasetti C, Ventriglio A, Bustini M, Pompili M, Serafini G, et al. Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32159712 DOI: 10.1590/1516-4446-2019-0690 |
0.56 |
|
| 2018 |
de Bartolomeis A, Iasevoli F, Marmo F, Buonaguro EF, Avvisati L, Latte G, Tomasetti C. Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29475793 DOI: 10.1016/J.Euroneuro.2018.01.006 |
0.786 |
|
| 2017 |
de Bartolomeis A, Buonaguro EF, Latte G, Rossi R, Marmo F, Iasevoli F, Tomasetti C. Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes. Frontiers in Behavioral Neuroscience. 11: 240. PMID 29321734 DOI: 10.3389/Fnbeh.2017.00240 |
0.802 |
|
| 2017 |
Buonaguro EF, Iasevoli F, Marmo F, Eramo A, Latte G, Avagliano C, Tomasetti C, de Bartolomeis A. Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28235555 DOI: 10.1016/J.Pnpbp.2017.02.012 |
0.805 |
|
| 2017 |
de Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review. International Journal of Molecular Sciences. 18. PMID 28208695 DOI: 10.3390/Ijms18020349 |
0.708 |
|
| 2017 |
Tomasetti C, Iasevoli F, Buonaguro EF, De Berardis D, Fornaro M, Fiengo AL, Martinotti G, Orsolini L, Valchera A, Di Giannantonio M, de Bartolomeis A. Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions. International Journal of Molecular Sciences. 18. PMID 28085108 DOI: 10.3390/Ijms18010135 |
0.752 |
|
| 2016 |
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, de Bartolomeis A, et al. Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine. Cns & Neurological Disorders Drug Targets. PMID 27781949 DOI: 10.2174/1871527315666161025140111 |
0.696 |
|
| 2016 |
De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, et al. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice. Cns Spectrums. 1-6. PMID 27702411 DOI: 10.1017/S1092852916000572 |
0.682 |
|
| 2016 |
Orsolini L, Valchera A, Vecchiotti R, Tomasetti C, Iasevoli F, Fornaro M, De Berardis D, Perna G, Pompili M, Bellantuono C. Suicide during Perinatal Period: Epidemiology, Risk Factors, and Clinical Correlates. Frontiers in Psychiatry. 7: 138. PMID 27570512 DOI: 10.3389/Fpsyt.2016.00138 |
0.515 |
|
| 2016 |
Buonaguro EF, Tomasetti C, Chiodini P, Marmo F, Latte G, Rossi R, Avvisati L, Iasevoli F, de Bartolomeis A. Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia. Journal of Psychopharmacology (Oxford, England). PMID 27443599 DOI: 10.1177/0269881116658987 |
0.817 |
|
| 2016 |
de Bartolomeis A, Marmo F, Buonaguro EF, Latte G, Tomasetti C, Iasevoli F. Switching antipsychotics: imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27177972 DOI: 10.1016/J.Pnpbp.2016.04.015 |
0.802 |
|
| 2016 |
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Bonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant Vortioxetine. Expert Review of Neurotherapeutics. PMID 27050932 DOI: 10.1586/14737175.2016.1173545 |
0.687 |
|
| 2015 |
de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. Cns Drugs. 29: 773-99. PMID 26346901 DOI: 10.1007/S40263-015-0278-3 |
0.751 |
|
| 2015 |
Iasevoli F, Giordano S, Balletta R, Latte G, Formato MV, Prinzivalli E, De Berardis D, Tomasetti C, de Bartolomeis A. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 65: 34-48. PMID 26320028 DOI: 10.1016/J.Pnpbp.2015.08.010 |
0.682 |
|
| 2015 |
De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Perna G, Piersanti M, Di Nicola M, Cavuto M, Martinotti G, et al. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. Cns & Neurological Disorders Drug Targets. PMID 26295824 DOI: 10.2174/1871527314666150821103825 |
0.668 |
|
| 2015 |
de Bartolomeis A, Errico F, Aceto G, Tomasetti C, Usiello A, Iasevoli F. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 62: 35-43. PMID 25979765 DOI: 10.1016/J.Pnpbp.2015.05.003 |
0.734 |
|
| 2015 |
De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, et al. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials. Current Drug Targets. 16: 1094-106. PMID 25944011 DOI: 10.2174/1389450116666150506114108 |
0.669 |
|
| 2015 |
Fornaro M, De Berardis D, Mazza M, Pino M, Favaretto E, Bedani F, Wieser C, Indelicato L, Paternò VF, Lo Monaco F, Dugo F, Ventriglio A, Mungo S, Selle V, Valchera A, ... ... Tomasetti C, et al. Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). Journal of Affective Disorders. 178: 112-20. PMID 25805403 DOI: 10.1016/J.Jad.2015.03.001 |
0.649 |
|
| 2015 |
de Bartolomeis A, Iasevoli F, Marmo F, Buonaguro EF, Eramo A, Rossi R, Avvisati L, Latte G, Tomasetti C. Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 566-82. PMID 25649681 DOI: 10.1016/J.Euroneuro.2015.01.003 |
0.809 |
|
| 2015 |
De Berardis D, Serroni N, Campanella D, Rapini G, Olivieri L, Feliziani B, Carano A, Valchera A, Iasevoli F, Tomasetti C, Mazza M, Fornaro M, Perna G, Di Nicola M, Martinotti G, et al. Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: an exploratory study. Comprehensive Psychiatry. 58: 82-7. PMID 25591904 DOI: 10.1016/J.Comppsych.2014.12.016 |
0.533 |
|
| 2015 |
De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, et al. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. International Journal of Molecular Sciences. 16: 1111-30. PMID 25569089 DOI: 10.3390/Ijms16011111 |
0.703 |
|
| 2015 |
Fornaro M, De Berardis D, De Pasquale C, Indelicato L, Pollice R, Valchera A, Perna G, Iasevoli F, Tomasetti C, Martinotti G, Koshy AS, Fasmer OB, Oedegaard KJ. Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: a systematic review. Comprehensive Psychiatry. 56: 1-16. PMID 25306379 DOI: 10.1016/J.Comppsych.2014.09.020 |
0.537 |
|
| 2014 |
de Bartolomeis A, Iasevoli F, Tomasetti C, Buonaguro EF. MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective. Molecular Neurobiology. PMID 25394379 DOI: 10.1007/S12035-014-8962-8 |
0.716 |
|
| 2014 |
Iasevoli F, Buonaguro EF, Sarappa C, Marmo F, Latte G, Rossi R, Eramo A, Tomasetti C, de Bartolomeis A. Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: relevance to schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 299-314. PMID 25025505 DOI: 10.1016/J.Pnpbp.2014.07.003 |
0.82 |
|
| 2014 |
Iasevoli F, Tomasetti C, Buonaguro EF, de Bartolomeis A. The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Current Neuropharmacology. 12: 219-38. PMID 24851087 DOI: 10.2174/1570159X12666140324183406 |
0.735 |
|
| 2014 |
de Bartolomeis A, Buonaguro EF, Iasevoli F, Tomasetti C. The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment. Journal of Psychopharmacology (Oxford, England). 28: 505-526. PMID 24554693 DOI: 10.1177/0269881114523864 |
0.742 |
|
| 2014 |
de Bartolomeis A, Latte G, Tomasetti C, Iasevoli F. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Molecular Neurobiology. 49: 484-511. PMID 23999870 DOI: 10.1007/S12035-013-8534-3 |
0.74 |
|
| 2013 |
Iasevoli F, Aloj L, Latte G, Avvisati L, Marmo F, Tomasetti C, Buonaguro EF, Simeoli C, Pivonello R, Colao A, de Bartolomeis A. The glucocorticoid analog dexamethasone alters the expression and the distribution of dopamine receptors and enkephalin within cortico-subcortical regions. Current Molecular Pharmacology. 6: 149-55. PMID 23862670 DOI: 10.2174/187446720603140415215941 |
0.779 |
|
| 2013 |
Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, De Berardis D, Martinotti G, Fornaro M, Mazza M, Tomasetti C, Buonaguro EF, Di Giannantonio M, Perugi G, de Bartolomeis A. Affective temperaments are associated with specific clusters of symptoms and psychopathology: a cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. Journal of Affective Disorders. 151: 540-50. PMID 23856282 DOI: 10.1016/J.Jad.2013.06.041 |
0.677 |
|
| 2013 |
de Bartolomeis A, Avvisati L, Iasevoli F, Tomasetti C. Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment. European Journal of Pharmacology. 718: 502-23. PMID 23834777 DOI: 10.1016/J.Ejphar.2013.06.034 |
0.719 |
|
| 2013 |
de Bartolomeis A, Sarappa C, Buonaguro EF, Marmo F, Eramo A, Tomasetti C, Iasevoli F. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 46: 1-12. PMID 23800465 DOI: 10.1016/J.Pnpbp.2013.06.010 |
0.814 |
|
| 2013 |
De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. International Journal of Molecular Sciences. 14: 12458-83. PMID 23765220 DOI: 10.3390/Ijms140612458 |
0.586 |
|
| 2013 |
De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. Cns & Neurological Disorders Drug Targets. 12: 252-64. PMID 23469841 DOI: 10.2174/1871527311312020012 |
0.693 |
|
| 2013 |
de Bartolomeis A, Marmo F, Buonaguro EF, Rossi R, Tomasetti C, Iasevoli F. Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1516-29. PMID 23357084 DOI: 10.1016/J.Euroneuro.2012.11.014 |
0.811 |
|
| 2013 |
Iasevoli F, Tomasetti C, de Bartolomeis A. Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases. Neurochemical Research. 38: 1-22. PMID 22991141 DOI: 10.1007/S11064-012-0886-Y |
0.689 |
|
| 2012 |
de Bartolomeis A, Tomasetti C. Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins. Molecular Neurobiology. 46: 275-96. PMID 22763587 DOI: 10.1007/s12035-012-8293-6 |
0.609 |
|
| 2012 |
de Bartolomeis A, Tomasetti C, Cicale M, Yuan PX, Manji HK. Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 527-35. PMID 22245542 DOI: 10.1016/J.Euroneuro.2011.11.006 |
0.619 |
|
| 2011 |
Tomasetti C, Dell'Aversano C, Iasevoli F, Marmo F, de Bartolomeis A. The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 184-97. PMID 21055435 DOI: 10.1016/J.Pnpbp.2010.10.025 |
0.811 |
|
| 2010 |
Iasevoli F, Tomasetti C, Marmo F, Bravi D, Arnt J, de Bartolomeis A. Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. Psychopharmacology. 212: 329-44. PMID 20652539 DOI: 10.1007/S00213-010-1954-0 |
0.808 |
|
| 2009 |
Iasevoli F, Tomasetti C, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A. Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 813-21. PMID 19243698 DOI: 10.1016/J.Pnpbp.2009.02.009 |
0.809 |
|
| 2009 |
Dell'aversano C, Tomasetti C, Iasevoli F, de Bartolomeis A. Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders. Brain Research Bulletin. 79: 123-9. PMID 19189858 DOI: 10.1016/J.Brainresbull.2009.01.006 |
0.772 |
|
| 2007 |
Ambesi-Impiombato A, Panariello F, Dell'aversano C, Tomasetti C, Muscettola G, de Bartolomeis A. Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain. Synapse (New York, N.Y.). 61: 429-39. PMID 17372981 DOI: 10.1002/syn.20385 |
0.761 |
|
| Show low-probability matches. |